Investigational cell therapy for frailty in older adults
This study tests an investigational treatment made from special cells (called mesenchymal stromal cells) that might help reduce frailty in older adults. The treatment is given through an IV and aims to improve strength and overall function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 60 and 85 years old.
- You are mildly or moderately frail (your doctor can confirm).
- You can walk between 200 and 400 meters in six minutes.
- You have a certain level of inflammation in your blood (TNF-alpha >2.5 pg/ml).
- You do not have serious health conditions like cancer, autoimmune disease, or severe heart or lung disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new stem cell medicine given through an IV to see if it is safe for older adults with mild to moderate frailty. Frailty causes weakness and tiredness, and this treatment aims to improve overall health and function.
This early study (Phase 1) tests whether a lab-made stem cell product given through an IV is safe in people with “aging frailty.” It looks mainly at side effects and safety while also exploring whether the treatment can be given safely.
This trial tests a personalized treatment approach for people aged 65 and older with newly diagnosed multiple myeloma. The goal is to tailor therapy based on each patient's level of frailty, which could help improve outcomes and reduce side effects.
This Phase 1/2 study tests whether transfusions of donated plasma can improve frailty and immune function in older adults. It mainly checks safety first, and also looks for signs that the immune system and overall strength may improve.
This trial tests a special exercise program designed for older adults who are frail or have muscle loss. The goal is to help improve strength and daily function, and participating may help you stay independent longer.
This early-stage study tests whether changing the gut bacteria using an oral stool-based treatment (called oral FMT) can improve health in older adults. It aims to see if this approach affects aging-related changes, including gut and body function.
Hear when a new Frailty trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.